Zoetis is a global animal health company, marketing pharmaceutical, biological and bio-pharma products for a wide range of animal species, including ruminants and poultry.
The Zoetis EU Research and Development headquarters are located in Belgium and host a team of researchers and regulatory experts, with expertise in the development and registration of biological products for the EU and global markets. Furthermore, Zoetis has a pilot and production plant located in Belgium for the development and production of vaccines.
Zoetis will contribute to WP1 (WS 3. Taking a Cooperia oncophora prototype vaccine forward), providing expertise on adjuvants, commercial recombinant protein expression and product development.